Are you Dr. Lopatin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1233 Howard St
Apt 716
San Francisco, CA 94103Phone+1 415-935-1874
Summary
- Dr. Uri Lopatin, MD is an infectious disease specialist in San Francisco, California. He is currently licensed to practice medicine in New York.
Education & Training
Rutgers New Jersey Medical SchoolClass of 2000
Certifications & Licensure
NY State Medical License 2002 - 2025
Publications & Presentations
PubMed
- 8 citationsEvaluation ofantiviral activity of SARS-CoV-2 Minhibitor pomotrelvir and cross-resistance to nirmatrelvir resistance substitutions.Xiao Tong, Walter Keung, Lee D Arnold, Laura J Stevens, Andrea J Pruijssers
Antimicrobial Agents and Chemotherapy. 2023-11-15 - 21 citationsSafety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.Mark S Sulkowski, Kosh Agarwal, Xiaoli Ma, Tuan T Nguyen, Eugene R Schiff
Journal of Hepatology. 2022-11-01 - 13 citationsSafety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection.Man-Fung Yuen, Kosh Agarwal, Xiaoli Ma, Tuan T Nguyen, Eugene R Schiff
Journal of Hepatology. 2022-09-01
Press Mentions
Pardes Biosciences Initiates First-in-Human Trial for PBI-0451, an Oral Antiviral in Development to Treat and Prevent SARS-CoV-2 InfectionsAugust 26th, 2021- Pardes Biosciences Appoints Deborah M. Autor, J.D. (’92) and Laura J. Hamill to Board of DirectorsAugust 5th, 2021
Shasqi Completes $10 Million Series A FinancingOctober 31st, 2019- Join now to see all
